Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review

dc.contributor.authorHarper, Diane M.
dc.contributor.authorNavarro Alonso, José A.
dc.contributor.authorBosch, F. Xavier
dc.contributor.authorPaavonen, Jorma
dc.contributor.authorStanley, Margaret
dc.contributor.authorSasieni, Peter
dc.contributor.authorYébenes, María
dc.contributor.authorMartínez Martínez, Néstor
dc.contributor.authorRodriguez, Ángela
dc.contributor.authorGarcía, Andrea
dc.contributor.authorMartín Gomez, Laura
dc.contributor.authorVallejo Aparicio, Laura
dc.contributor.authorCarrión, Helena
dc.contributor.authorRuiz García, Yara
dc.date.accessioned2025-07-16T09:24:54Z
dc.date.available2025-07-16T09:24:54Z
dc.date.issued2025-06-09
dc.date.updated2025-07-14T14:24:12Z
dc.description.abstractCervical cancer is a preventable disease for which vaccines are available to provide long-term protection against human papillomavirus (HPV) infection. This systematic literature review (SLR) was performed to summarize the efficacy, effectiveness, impact, duration of protection, and safety profile of four licensed HPV vaccines against infection, precursor lesions, and cervical cancer. Data was extracted from published reports. The search resulted in 1,136 studies, of which 54 were selected for this review. A substantial decrease in the prevalence of oncogenic HPV types, high-grade cervical lesions, and cervical cancer was found in countries with high vaccine coverage and routine vaccination programs. Post-licensure studies of HPV vaccines have reported high efficacy, effectiveness, and health impact across settings and age groups. Studies emphasize vaccination in younger age groups. These findings may inform future discussions about HPV vaccination strategies.
dc.format.extent24 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2164-554X
dc.identifier.pmid40485552
dc.identifier.urihttps://hdl.handle.net/2445/222281
dc.language.isoeng
dc.publisherInforma UK Limited
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1080/21645515.2025.2497608
dc.relation.ispartofHuman Vaccines & Immunotherapeutics, 2025, vol. 21, num. 1, p. 2497608
dc.relation.urihttps://doi.org/10.1080/21645515.2025.2497608
dc.rightscc by-nc (c) Harper, Diane M. et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationVacuna del papil·lomavirus
dc.subject.classificationCàncer de coll uterí
dc.subject.otherPapillomavirus vaccines
dc.subject.otherCervix cancer
dc.titleImpact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Impact of human papillomavirus vaccines in the reduction of infection precursor lesions and cervical cancer A systematic literature review.pdf
Mida:
4.09 MB
Format:
Adobe Portable Document Format